Entrada Therapeutics, Inc.
NASDAQ:TRDA · NASDAQ Global Market
+$0.03 today
Vol 0.31M · Avg 0.36M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+0.71%
Period High
$16.03
Period Low
$5.02
Latest
$7.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.31B
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$502.81M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$486.52M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$347.88M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$345.32M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$223.26M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$216.34M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$211.18M
Immuneering Corporation
NASDAQ:IMRX
$157.01M
Humacyte, Inc.
NASDAQ:HUMA
$155.58M
What is the latest TRDA filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does TRDA have?
Intrinsic Alpha currently shows 20 recent filings for TRDA.
Explore More
Continue the stock analysis
Jump to another research area for this company.